Back
Neurocrine Biosciences Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
66
NBIX
Neurocrine Biosciences
Last Price:
$133.45
Seasonality Move:
3.97%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIX is experiencing slight selling pressure.
Neurocrine Biosciences Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 130.63 | Buy |
20-day SMA: | 127.89 | Buy |
50-day SMA: | 123.19 | Buy |
200-day SMA: | 121.88 | Buy |
8-day EMA: | 84.39 | Buy |
20-day EMA: | 43.83 | Buy |
50-day EMA: | 19.63 | Buy |
200-day EMA: | 5.2 | Buy |
Neurocrine Biosciences Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 29.61 | Buy |
Relative Strength Index (14 RSI): | 67.75 | Buy |
Chaikin Money Flow: | -45572 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (124.4 - 130.2) | Buy |
Bollinger Bands (100): | (105.24 - 126.02) | Buy |
Neurocrine Biosciences Technical Analysis
Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 133.46 while NBIX 8-day simple moving average is 130.63, which is a Buy signal.
-
The stock price of NBIX is 133.46 while Neurocrine Biosciences 20-day SMA is 127.89, which makes it a Buy.
-
Neurocrine Biosciences 50-day simple moving average is 123.19 while NBIX share price is 133.46, making it a Buy technically.
-
NBIX stock price is 133.46 and Neurocrine Biosciences 200-day simple moving average is 121.88, creating a Buy signal.
NBIX Technical Analysis vs Fundamental Analysis
Buy
66
Neurocrine Biosciences (NBIX)
is a Buy
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a BuyThe current Neurocrine Biosciences [NBIX] share price is $133.46. The Score for NBIX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
13.2B
Price in USD:
133.46
Share Volume:
724.8K
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
84.23
Buy
66
Neurocrine Biosciences (NBIX)
is a Buy
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?The Neurocrine Biosciences stock price is 133.46 USD today.
-
Will NBIX stock go up or go down?Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators
-
Is Neurocrine Biosciences overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is not overvalued.
Is Neurocrine Biosciences Stock a Buy?
-
Neurocrine Biosciences share price is 133.46 while NBIX 8-day exponential moving average is 84.39, which is a Buy signal.
-
The stock price of NBIX is 133.46 while Neurocrine Biosciences 20-day EMA is 43.83, which makes it a Buy.
-
Neurocrine Biosciences 50-day exponential moving average is 19.63 while NBIX share price is 133.46, making it a Buy technically.
-
NBIX stock price is 133.46 and Neurocrine Biosciences 200-day simple moving average is 5.20, creating a Buy signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.26 per share, a decrease this year of $0.51 per share, and an increase next year of $2.29 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
-
NBIX Moving Average Covergence Divergence (MACD) indicator is 29.61, suggesting Neurocrine Biosciences is a Buy
-
Neurocrine Biosciences Relative Strength Index (RSI) is 67.75, which suggest Neurocrine Biosciences is overbought
-
The Bollinger Bands (25) for Neurocrine Biosciences is (124.4 - 130.2), which suggest Neurocrine Biosciences is a Buy
-
The Bollinger Bands (100) for Neurocrine Biosciences is (105.24 - 126.02), which suggest Neurocrine Biosciences is a Buy
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.